STERIS plc — Director's Dealing 2020

Oct 13, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STERIS plc (STE)
CIK: 0001757898
Period of Report: 2020-10-08

Reporting Person: TOKICH MICHAEL J (Sr. Vice Pres., CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-10-08	Ordinary Shares	M	80	$53.52	Acquired	45602	Direct
2020-10-08	Ordinary Shares	S	80	$187.00	Disposed	45522	Direct
2020-10-09	Ordinary Shares	M	27920	$53.52	Acquired	73442	Direct
2020-10-09	Ordinary Shares	S	6000	$187.17	Disposed	67442	Direct
2020-10-09	Ordinary Shares	S	15677	$188.24	Disposed	51765	Direct
2020-10-09	Ordinary Shares	S	6243	$189.00	Disposed	45522	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-10-08	Employee Stock Option (right to buy)	$53.52	M	80	Acquired	2024-05-30	Ordinary Shares (80)	Direct
2020-10-09	Employee Stock Option (right to buy)	$53.52	M	27920	Acquired	2024-05-30	Ordinary Shares (27920)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	3453	Indirect

Footnotes

F1: 15,472 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,000 on June 1, 2021; 4,240 on May 31, 2022; 2,780 on May 31, 2023 and 2,452 on June 3, 2024.

F2: This exercise of stock options and sale of a total of 80 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on June 2, 2020.

F3: This exercise of stock options and sale of a total of 6,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on June 2, 2020.

F4: Price reflects a weighted average sale price for multiple transactions ranging from $186.61 to $187.59 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F5: This exercise of stock options and sale of a total of 15,677 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on June 2, 2020.

F6: Price reflects a weighted average sale price for multiple transactions ranging from $187.6950 to $188.68 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F7: This exercise of stock options and sale of a total of 6,243 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on June 2, 2020.

F8: Price reflects a weighted average sale price for multiple transactions ranging from $188.6950 to $189.2850 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F9: Units representing 3,453 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS 401(k) Plan as of October, 2020.

F10: This option to purchase 28,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 28,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law.